HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ('Nutex Health' or the 'Company') (NASDAQ: NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024.

。

The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol 'NUTX' but with new CUSIP number 67079U306. The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for the continued listing on The Nasdaq Capital Market..

反向股票分割将于2024年7月2日东部时间下午11:59生效，公司普通股将于2024年7月3日在纳斯达克资本市场公开交易，股票代码为“NUTX”，但新CUSIP编号为67079U306。反向股票分割是该公司计划的一部分，该计划旨在重新遵守继续在纳斯达克资本市场上市的最低出价要求。。

The reverse split was authorized by the Company's shareholders on June 17, 2024, granting the Company's Board of Directors (the 'Board') the discretion to determine the timing and ratio of the split within a range of 1-2 and 1-16. The Board has now decided on the 1-for-10 ratio and will amend the Company's Amended and Restated Certificate of Incorporation to reflect this change.

2024年6月17日，公司股东授权反向拆分，授予公司董事会（“董事会”）酌情决定在1-2和1-16的范围内确定拆分的时间和比例。董事会现已决定10比1的比例，并将修订公司经修订和重述的公司注册证书，以反映这一变化。

This reverse stock split is in addition to the Company's previous 1 for 15 reverse stock split which was effective April 10, 2024..

该反向股票分割是对该公司之前于2024年4月10日生效的15对1反向股票分割的补充。。

As a result of the reverse stock split, every ten shares of the Company's common stock issued and outstanding prior to the opening of trading on July 3, 2024 will be consolidated into one issued and outstanding share, with no change in the nominal par value per share of $0.001.  No fractional shares will be issued as a result of the reverse stock split.  Stockholders of record who would otherwise be entitled to receive a fractional share will be entitled to the rounding up of the fractional share to the nearest whole number, as determined by DTC at the participant level..

由于反向股票分割，公司在2024年7月3日开市前发行和流通的普通股中，每10股将合并为一股已发行和流通的股票，每股票面价值0.001美元不变。反向股票分割不会发行零股。有权获得零碎股份的登记股东将有权将零碎股份四舍五入至最接近的整数，由参与者层面的DTC确定。。

As a result of the reverse stock split, the number of common shares outstanding will be reduced from approximately 49 million shares to approximately 4.9 million shares, and the number of authorized shares of common stock will remain at 950 million shares.  In addition, the number of shares reserved for issuance under the Company's equity compensation plan immediately prior to the reverse stock split will be reduced proportionately.  Adjustments will also be made to the Company's outstanding warrants and stock options.

由于反向股票分割，已发行的普通股数量将从约4900万股减少到约490万股，普通股的授权股数将保持在9.5亿股。此外，在反向股票分割之前，根据公司股权补偿计划保留发行的股份数量将按比例减少。还将对公司的未偿认股权证和股票期权进行调整。

The number of shares into which these securities are convertible or exercisable will be adjusted in line with the reverse split, as will the exercise prices of these securities..

这些证券可转换或可行权的股份数量将根据反向分割进行调整，这些证券的行权价格也将进行调整。。

About Nutex Health Inc.

关于Nutex Health Inc。

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks with two divisions: a Hospital Division and a Population Health Management Division..

Nutex Health Inc.（纳斯达克股票代码：NUTX）总部位于德克萨斯州休斯顿，成立于2011年，是一家以医生为主导、以技术为基础的综合医疗服务系统，由9个州的21家最先进的微型医院和以初级保健为中心、承担风险的医生网络组成，下设两个部门：医院部门和人口健康管理部门。。

The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 21 facilities in nine states.

医院部门拥有、开发和运营创新的医疗保健模式，包括微型医院、专科医院和医院门诊部（HOPD）。该部门在9个州拥有并运营21家工厂。

The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups.  Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently. .

人口健康管理司拥有并运营独立医师协会（IPA）等提供者网络。。我们基于云的专有技术平台跨多个设置、信息系统和来源汇总临床和索赔数据，以创建患者和提供者的整体视图，使我们能够更有效地提供更高质量的护理。。

Forward-Looking Statements

前瞻性声明

Certain statements and information included in this press release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases 'will', 'will likely result,' 'expected to,' 'will continue,' 'anticipated,' 'estimate,' 'projected,' 'intend,' 'goal,' or similar expressions are intended to identify 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995.

本新闻稿中的某些声明和信息构成1995年《私人证券诉讼法》所指的“前瞻性声明”。当在本新闻稿中使用“将”、“可能结果”、“预期将”、“将继续”、“预计”、“估计”、“预计”、“打算”、“目标”或类似词语时，旨在识别1995年《私人证券诉讼改革法》所指的“前瞻性声明”。

Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company.  Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing.

此类报表存在某些已知和未知的风险以及不确定性，其中许多风险超出了公司的控制范围。这些不确定性和风险包括但不限于我们成功执行增长战略的能力、法律法规的变化，包括根据《不意外法案》实施的临时最终和最终规则、经济状况、对管理层的依赖、股东稀释、资本缺乏、快速增长对公司的影响以及管理层有效应对公司产品和服务增长和需求的能力、新开发的技术、公司的竞争能力、关联方交易中的利益冲突、监管事项、技术保护、缺乏行业标准、竞争的影响以及公司获得未来融资的能力。

An extensive list of factors that can affect future results are discussed in our Annual Report on Form 10-K for the year ended December 31, 2023 and the Quarterly Report on Form 10-Q for the quarter ended March 30, 2024 under the heading 'Risk Factors' in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission.

我们在截至2023年12月31日的年度报告表10-K和截至2024年3月30日的季度报告表10-Q中讨论了可能影响未来结果的大量因素，这些因素列在第一部分第IA项的“风险因素”标题下，以及不时向证券交易委员会提交的其他文件中。

Such factors could mat.

这些因素可能会产生影响。

SOURCE Nutex Health, Inc.

来源Nutex Health，Inc。